These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8540723)

  • 1. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
    Gavaldà J; Pahissa A; Almirante B; Laguarda M; Crespo E; Pou L; Fernández F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci.
    Brandt CM; Warner CB; Rouse MS; Steckelberg JM; Wilson WR
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2901-3. PubMed ID: 9124865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.
    Saleh-Mghir A; Cremieux AC; Vallois JM; Muffat-Joly M; Devine C; Carbon C
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2403-7. PubMed ID: 1489184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis.
    Enzler MJ; Rouse MS; Henry NK; Geraci JE; Wilson WR
    J Infect Dis; 1987 May; 155(5):954-8. PubMed ID: 3644854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.
    Henry NK; Wilson WR; Roberts RB; Acar JF; Geraci JE
    Antimicrob Agents Chemother; 1986 Sep; 30(3):465-7. PubMed ID: 3777910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals.
    Wilson WR; Zak O; Sande MA
    J Infect Dis; 1985 Jun; 151(6):1028-33. PubMed ID: 3846608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis.
    Wright AJ; Wilson WR; Matsumoto JY; Washington JA; Geraci JE
    Antimicrob Agents Chemother; 1982 Dec; 22(6):972-5. PubMed ID: 6818902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.
    Fantin B; Carbon C
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2387-91. PubMed ID: 2128443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
    García-de-la-Mària C; Pericas JM; Del Río A; Castañeda X; Vila-Farrés X; Armero Y; Espinal PA; Cervera C; Soy D; Falces C; Ninot S; Almela M; Mestres CA; Gatell JM; Vila J; Moreno A; Marco F; Miró JM;
    Antimicrob Agents Chemother; 2013 May; 57(5):2319-25. PubMed ID: 23478959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.
    Fernandez-Guerrero M; Rouse MS; Henry NK; Geraci JE; Wilson WR
    Antimicrob Agents Chemother; 1987 Mar; 31(3):430-3. PubMed ID: 3579260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.
    Cercenado E; Díaz MD; Sánchez-Carrillo C; Vicente T; Bernaldo de Quirós JC
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2816-8. PubMed ID: 8593029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R
    Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
    Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis.
    Marangos MN; Nicolau DP; Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 1997 Apr; 39(4):519-22. PubMed ID: 9145826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricuspid valve endocarditis due to a moderately susceptible Streptococcus constellatus: persistent bacteremia and fatal outcome despite penicillin plus gentamicin therapy.
    Baran J; Abdo WM; Merritt KW; Khatib R
    Scand J Infect Dis; 1998; 30(4):420-1. PubMed ID: 9817527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Carbon C; Gutmann L
    J Infect Dis; 1991 Nov; 164(5):888-93. PubMed ID: 1940467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
    Martínez F; Martín-Luengo F; García A; Valdés M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillin sensitive nutritionally variant streptococcal endocarditis: relapse after penicillin therapy.
    Levine JF; Hanna BA; Pollock AA; Simberkoff MS; Rahal JJ
    Am J Med Sci; 1983; 286(1):31-6. PubMed ID: 6553451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin.
    Henry NK; Wilson WR; Geraci JE
    Antimicrob Agents Chemother; 1986 Nov; 30(5):725-8. PubMed ID: 3800348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.